What does a prostate pathology report indicating pT3a (extraprostatic extension), Gleason 3 + 4 (Gleason score 7), positive surgical margin, and positive extraprostatic extension mean?

Understanding Your Prostate Pathology Report

This pathology report indicates high-risk prostate cancer that has spread beyond the prostate capsule with cancer cells at the surgical edge—this significantly increases your risk of cancer recurrence and you should have a detailed discussion about adjuvant radiotherapy with your treatment team.

What Each Finding Means

pT3a (Extraprostatic Extension - EPE)

• The cancer has broken through the prostate capsule and extended into surrounding tissue, but has not reached the seminal vesicles 1
• This is considered locally advanced disease, not organ-confined
• pT3a disease carries approximately one-third risk of recurrence within a decade after surgery alone 2

Gleason 3+4 (Gleason Score 7)

• This represents intermediate-grade prostate cancer 1
• The "3+4" means the predominant pattern is Gleason 3 (less aggressive), with a secondary pattern of Gleason 4 (more aggressive)
• Gleason 3+4 has better prognosis than Gleason 4+3, even though both equal 7, because the primary pattern matters 1, 3
• However, the presence of any Gleason pattern 4 indicates more aggressive biology than pure Gleason 6 disease

Positive Surgical Margin

• Cancer cells were found at the inked edge of the removed tissue, meaning the surgeon could not remove all visible cancer with a rim of normal tissue 2
• This is one of the most important adverse pathological findings after prostatectomy
• Positive margins increase your risk of biochemical recurrence to approximately 22% compared to 5.6% with negative margins 4

EPE Positive (Confirmed)

• This reiterates that extraprostatic extension was definitively identified on pathology
• The combination of EPE + positive margins + Gleason 3+4 places you at elevated risk for cancer recurrence 2

What This Means for Your Treatment

You Are a Candidate for Adjuvant Radiotherapy

Physicians should offer you adjuvant radiotherapy because patients with your exact pathological findings (positive surgical margins and extraprostatic extension) have demonstrated reductions in biochemical recurrence, local recurrence, and clinical progression when treated with radiation after surgery 2.

The evidence shows:

• Adjuvant radiotherapy reduces PSA recurrence, local recurrence, and clinical progression compared to surgery alone 2
• The impact on metastases and overall survival is less clear, with mixed trial results 2
• Not all patients with adverse pathology have equal risk—those with Gleason 8-10, seminal vesicle invasion, extensive positive margins, or detectable post-operative PSA have the highest risk 2

Important Nuances About Your Specific Findings

Your Gleason 3+4 (rather than 4+3 or higher) is relatively favorable within the adverse pathology spectrum. However:

• The Gleason score at your positive margin matters—if the margin shows Gleason pattern 4, this carries higher recurrence risk than if only pattern 3 is at the margin 5, 6, 4
• The length of the positive margin matters—margins ≥3mm carry significantly higher recurrence risk 5
• The number of positive margin sites matters—multiple positive margins (≥2) significantly increase recurrence risk 5

Your pathology report should specify these margin details. If not documented, request clarification from your pathologist.

What Happens Next

Immediate Monitoring

• PSA should be monitored regularly after surgery to detect biochemical recurrence early 2
• Biochemical recurrence is defined as PSA ≥0.2 ng/mL with a confirmatory second level ≥0.2 ng/mL 2
• Early detection of PSA rise allows for salvage therapy when most effective

The Adjuvant vs. Salvage Decision

This is where the "offer" of adjuvant radiotherapy becomes nuanced:

Adjuvant radiotherapy means radiation given soon after surgery, before PSA rises:

• Reduces recurrence risk across all adverse pathology groups 2
• The absolute benefit depends on your absolute recurrence risk
• Must be weighed against radiation side effects (urinary, bowel, sexual) 2

Salvage radiotherapy means waiting for PSA to rise, then treating:

• Also effective, but most effective when PSA is still low 2
• Allows some patients to avoid radiation if they never recur
• Risk is that waiting may reduce effectiveness

Common Pitfalls to Avoid

1. Not all pT3a with positive margins need immediate radiation—your overall Gleason 3+4 (not 8-10), absence of seminal vesicle invasion, and post-operative PSA level all factor into the absolute benefit calculation 2

2. The margin Gleason score and extent matter—if your margin shows only Gleason pattern 3 and is focal (<3mm), your recurrence risk may be lower than extensive Gleason 4 at the margin 5, 6, 4

3. Radiation has real side effects—the decision requires balancing your specific recurrence risk against quality of life impacts from urinary, bowel, and sexual dysfunction 2

The Bottom Line

Your pathology shows adverse features that increase cancer recurrence risk, making you a candidate for additional therapy. The decision between immediate adjuvant radiation versus close PSA monitoring with early salvage radiation should be made through detailed discussion with your multidisciplinary team (urologist, radiation oncologist), considering:

• Your exact margin details (Gleason score at margin, length, number of sites)
• Your post-operative PSA level
• Your age and life expectancy
• Your baseline urinary, bowel, and sexual function
• Your tolerance for uncertainty versus treatment side effects

Request a multidisciplinary consultation that includes both urology and radiation oncology to review these factors and make an informed decision aligned with your values and preferences 2, 7.